Cardiology

Duration of antiplatelet drugs for drug-eluting stents studied

(HealthDay)—In patients receiving drug-eluting stents, dual antiplatelet therapy can be safely discontinued during the first year, according to two studies published online Sept. 19 in the Journal of the American College ...

Cardiology

Omission of aspirin from antiplatelet regimen: The WOEST study

Lifelong anticoagulation is necessary for the prevention of stroke in patients with rhythm disturbances and with mechanical valves. Patients who have a coronary stent implanted also need the antiplatelet drugs aspirin and ...

Cardiology

DAPT use variable in patients with A-fib at risk of stroke

(HealthDay)—For patients with atrial fibrillation at moderate to high risk of stroke, dual antiplatelet therapy (DAPT) use is variable among those undergoing percutaneous coronary intervention (PCI), according to a study ...

Gastroenterology

Management of antithrombotics in GI bleed, endoscopy addressed

In a clinical practice guideline issued jointly by the American College of Gastroenterology and the Canadian Association of Gastroenterology and published online March 17 in the American Journal of Gastroenterology, updated ...

Cardiology

Results of the DESERT registry reported at TCT 2011

The risk of late stent thrombosis (ST) in the first generation of drug-eluting stents continues for up to seven years after implantation, and certain types of patients, including smokers and those who are younger, are at ...

page 3 from 9